Registrations are CLOSED!

This Masterclass’ seats are almost SOLD OUT, 104 out of 112

Only 6 seats left!

IMPORTANT: The new registrations will be accepted directly onsite (only credit card payments will be accepted)  

The Masterclass is organised by EACTAIC Education Committee in collaboration with the EACTAIC LVAD and Transplantation Subspeciality Committee and Onassis Cardiac Surgery Centre, Athens, Greece.

Onassis Cardiac Surgery Centre sponsored the Masterclass with an unrestricted educational grant.

The Masterclass will be held in Buildings K8, K2, K3 at the HELLENIC PASTEUR INSTITUTE, ATHENS, GREECE. 

Chair of the Organising Committee: Mohamed R. el Tahan, MD, Cardiac anesthesiologist, Mansoura University, Mansoura, Egypt, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia 

Chair of the Scientific Committee: Eric E.C. de Waal, MD, PhD, Cardiac anesthesiologist, University Medical Center Utrecht, Netherlands, Chair of the VAD and Transplantation Committee. 

Chair of the Local Organising Committee: Theofani Antoniou, Cardiac anesthesiologist, Director of Medical Services, Chair Anaesthesiology Department, Onassis Cardiac Surgery Center, Athens, Greece. Head of Department and Programmes Director of EACTAIC Adults and Paediatric Fellowships at the OCSC. 

Organizing committee

Theofani Antoniou
Stavros Dimopoulos
Antigoni Koliopoulou
Nandor Marczin
Mohamed R. El Tahan
Eric E.C. de Waal

Alexandra Briassouli

Learning Objectives

  • Understand and interpret stages of end-stage heart failure/cardiogenic shock.
  • Understand indications for short term left ventricular assist devices.
  • Review concepts, configurations and complications of extracorporeal membrane oxygenation.
  • Indicate optimization of patients scheduled for LVAD implantation.
  • Understand perioperative complications of LVAD implantations, such as right ventricular failure.
  • How to resuscitate patients with an LVAD.
  • Understand future aspects in the treatment of end-stage heart failure.

Target Audience:

Anaesthesiology, Cardiothoracic Surgery, Intensive Care Medicine, Cardiology, Surgery, Thoracic Surgery, Echocardiography, Vascular Surgery, Respiratory Therapy, Perfusionist, Rehabilitation, Physiotherapy, Nursing.

The EACTAIC ECMO-LVAD masterclass, Athens, Greece, 25/11/2022-26/11/2022 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 14 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the  Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

logo 2015 900x900

 

CME Credits

Please remember to sign your entry end exit times in the dedicated lists placed outside each room to gain the CME Credits.

 

 

 

Registrations are CLOSED!

This Masterclass' seats are almost SOLD OUT, 104 out of 112

Only 6 seats left!

IMPORTANT: The new registrations will be accepted directly onsite (only credit card payments will be accepted)  

FEES:

Non-Greek participants: 

Regular: 350 Euros (VAT incl)

Training residents*/certified nurses, perfusionists: 200 Euros (VAT incl)

*For training residents: please upload a proof of your status as a training resident.

 

Greek residents participants* (physicians, training residents, certified nurses, and perfusionists): 100 Euros (VAT incl).

*Greek residents participants will be asked a proof of residence to complete the registration.

 

CANCELLATION POLICY:

Notification of cancellation must be sent in writing to AIM GROUP INTERNATIONAL - eactaic.masterclass@aimgroup.eu and eactaic@aimgroup.eu

Cancellations will be accepted until October 21 2022 with a refund of all prepaid fees except for a 15% administrative charge. No refunds will be made for cancellations received after this date. All approved refunds will be processed and issued 60 days after the Congress.

 

Hotels close to the Hellenic Pasteur Institute

1. Airotel Alexandros, 4*, Alexandroupoleos 23, 500 mt/5 min walking from the Congress Venue. Link for reservation: https://www.airotel.gr/en/

2. President Hotel, 4*, Κifisias 43. – Αthens, 600 mt/8 min walking from the Congress Venue. Link for reservation: https://president.gr/

3. The Golden Age Hotel, 4*, Michalakopoulou 57, 1 km/12 min walking from the Congress Venue. Link for reservation: https://hotelgoldenage.com/

4. Athinais Hotel, 3*, Vasilissis Sofias 99, 350 mt/4 min walking from the Congress Venue. Link for reservation: https://www.athinaishotel.gr/

5. Elizabeth Hotel, 2*, 46 Arkadias, 850 mt/12 walking from the Congress Venue. Link for reservation: https://elizabeth-hotel.hotelsathens.org/en/#main

Day 1 – Friday
09:00 – 17:45

Theoretical day

08:00 – 09:00  Registrations

09:00 - 10:30 End-stage heart failure and short-term devices
Chairs: Theofani Antoniou (Athens, Greece), Stavros Dimopoulos (Athens, Greece)
09:00 – 09:10 Welcome and introduction to the EACTAIC ECMO-VAD masterclass. Mohamed R. El Tahan (EACTAIC Education Chair, Mansoura, Egypt)
09:10 – 09:30 Setting the scene: Options in management of Intermacs 1 patients. Eric de Waal (Utrecht, Netherlands).
09:30 – 09:50 Pros and cons of Intra-Aortic Balloon Pump. Aggeliki Gkouziouta (Athens, Greece).
09:50 – 10:10 Pros and cons of Impella device. Ana Hurtado (London, United Kingdom).
10:10 – 10:30 Importance of unloading LV in end-stage heart failure. Michael Bonios (Athens, Greece).

10:30 – 11:00   Coffee break

11:00 - 12:00 ECMO
Chairs: Philippe Gaudard (France), Antigone Koliopoulou (Athens, Greece)
11:00 – 11:20 Types of ECMO, indications and anticoagulation strategies. Chinmay Patvardhan (Papworth, UK).
11:20 – 11:40 ECMO complications. Antigone Koliopoulou (Athens, Greece).
11:40 – 12:00 Patient management during ECMO support and weaning protocols. Stavros Dimopoulos (Athens, Greece).

12:00 – 12:30 Lunch Break 

12:30 – 13:30 INDUSTRY SPONSORED SYMPOSIUM 

13:30 – 13:40 Short break

13:40 - 15:00 LVAD
Chairs: Chris Bowles (Harefield, United Kingdom), Eric de Waal (Utrecht, The Netherlands)
13:40 – 14:00 Preoperative optimization of patients scheduled for VAD implantation. Vera von Dossow (Bad Oeynhausen, Germany).
14:00 – 14:20 Perioperative coagulation disorders. Daniel Bolliger (Basel, Switzerland).
14:20 – 14:40 The current status of minimally invasive implantation techniques and anaesthetic implications. Nandor Marczin (London, UK).
14:40 –15:00  RV Failure: risk stratification and strategies. 
Ana Hurtado (London, United Kingdom).

15:00 – 15:20 Coffee break

15:20 - 16:00 ICU
Chairs: Vera von Dossow (Bad Oeynhausen, Germany), Ana Hurtado  (Harefield, United Kingdom)
15:20 – 15:40 Postoperative management in the ICU. Philippe Gaudard (Montpellier, France).
15:40 – 16:00 Prevention of long-term complications after LVAD implantation. Martin Dworschak (Vienna, Austria).

16:00 - 17:20 Round table discussion: Future aspects 

Chairs: Nandor Marczin (Harefield, London, United Kingdom), Eric de Waal (Utrecht, The Netherlands)                              
16:00 – 16:20 New molecular and cell therapies for heart failure. Aris Anastasakis (Athens, Greece).
16:20 – 16:40 Emerging and future devices for mechanical support. Vera von Dossow (Bad Oeynhause, Germany)

16:40 – 17:00 Transplantation remains the goal. Nandor Marczin (Harefield, London, United Kingdom)
17:00 – 17:20 Discussion

17:20 – 17:50 Meet the expert - 2 case presentations with interactive discussion: Tops and tips. Vera von Dossow (Bad Oeynhause, Germany), Eric de Waal (Utrecht, The Netherlands).
17:50-18:10 Closure and introduction working stations on day 2. Stavros Dimopoulos (Athens, Greece).

Day 2 – Saturday
08:00 – 19:00

 

Practical Day

Attendees will be divided into groups to join the stations sequentially. It depends on how many registrations we will have, but thinking about 98-112 delegates, we can devide them into 14 groups of each 7-8 delegates. 25 minutes per workshop and a 5 min time for rotation delivers the table given below. There will be two practical courses (morning and afternoon), so as to have 7 or 8 *  8 = 49 -56 attendees twice. Maximum number will be 112 attendees.

 

Simulation based on the suggestion having 98 - 112 delegates into 16 groups over 25-minute rotations over the seven WS (7-8 delegates in each group).

 

Working stations

9.25-9:55: break

11:30-11:50: break

12:15-12:45: lunch break

14:10-14:30: break

16:05-16:25: break

 

WS 1. ECMO set-up, configurations, function, monitoring.

Nektarios Kogerakis (Athens, Greece), Chinmay Patvardhan (Papworth, UK).

 

(Contents & summary: Extracorporeal membrane oxygenation (ECMO) can provide short term circulatory support for acute heart failure or post cardiotomy cardiogenic shock. ECMO has also played a major part in H1N1 and COVID-19 pandemic. Yet, ECMO pushes the boundaries of what we know about physiology, pathology and pharmacology)

 

WS 2. ECMO circuit change, pump/oxygenator change.

Socrates Fragoulis (Athens, Greece), Prodromos Zavaropoulos (Athens, Greece).

 

WS 3. ECMO troubleshooting (in a clinical scenario).

Stavros Dimopoulos (Athens, Greece), Philippe Gaudard (Montpellier, France).

(Contents & summary: We will focus on interpreting and hands-on managing ECMO flow and pressures (P1, P2, P3) on a Cardiohelp-devices.

Emphasis will be given to interaction. The time for the working station is 25 min. during this working station, clinical scenarios in which ECMO troubleshooting cases will be analyzed will be presented)

 

WS 4. Wetlab: LVAD implantation.

Konstantinos Ieromonachos. (Athens, Greece), Dimitrios Zarkalis (Athens, Greece)

 

WS 5. Demo HMIII LVAD simulation station

Antigone Koliopoulou (Athens, Greece), Giuseppe Ciccarello (Abbott, Italy)

(Contents & summary: The station will include two HM3 demo pumps, monitors and power modules of the HM3, provided by Abbott. The simulation will cover most of the clinical situations, such as HM3 parameter fluctuations at different time points we are facing everyday with our patients clinical scenarios and:  

- starting and managing the device at the OR

- immediate postoperative period in the ICU, troubleshooting postoperative issues (low flow alarms, hypovolemia and fluid management, RV dysfunction, tamponade)

- at the Ward and after hospital discharge: fluid management, hypertension, low flow, PI events, outflow graft twist, arrhythmias, suspected pump thrombosis)

 

WS 6. PBL discussion: LV and RV haemodynamics in LVAD implantation.

Stefaan Bouchez (Aalst, Belgium), Nandor Marczin (London, UK)

(Contents & summary: Simulation of different scenarios to show what’s really happening to the LV and RV during LVAD support)

WS 7. Resuscitation guidelines of a patient with LVAD.

Chris Bowles (Harefield, United Kingdom), Ana Hurtado (Harefield, UK), Waqas Akhtar (Harefield, UK).

(Contents & summary: Introduction of LVAD mechanical life support algorithm, Algorithm rationale, Common emergency scenarios, Simulation experience )

 Lecture: Ventricular Assist Devices & Emergency Algorithm 

Skills station: emergency simulation: 

            1. Low/critical battery 

            2. Controller failure 

            3. High Watts 

            4. Driveline disconnection 

            5. Blank controller 

            6. Low Flow alarm 

            7. VT/VF scenario 

            8. CALS/CPR & standad ALS 

 

STATEMENT:

The participants are all informed that:

• during practical sessions will be used specific medical devices.

• there is a variety of different similar products that participants can use beyond the one provided at the event

 

12:30-12:45 Introduction to hemoadsorption with Cytosorb. Marijana Matejic-Spasic (Berlin, Germany)

12:45-13:00 The application of Cytosorb in temporary and durable mechanical support. Eric de Waal (Utrecht, The Netherlands)

13:00-13:15 Role for CytoSorb in Ticagrelor and DOAC Removal in Emergency and High-risk Cardiac Surgery. Nandor Marczin (Harefield, UK)

13:15-13:30 Discussion

 

 

Unrestricted grant - Platinum Sponsors

The Onassis Cardiac Surgery Center is the premier cardiovascular surgery and interventional cardiology hospital in Southeastern Europe. It was donated to the Greek State by the Onassis Foundation. It provides a complete spectrum of services in cardiac surgery and cardiology for all forms of acquired and congenital heart disease, including TAVI and TMVI techniques, minimally invasive mitral valve repair, pacemaker and defibrillator implantations, heart and lung transplantation and VAD implantation.

 

Gold Sponsors

CytoSorbents a leader in the treatment of life-threatening conditions in the ICU and cardiac surgery using blood purification via its proprietary polymer adsorption technology. Its flagship product, CytoSorb®, is distributed in 70+ countries and has CE Mark approval in the EU for cytokine, bilirubin and myoglobin removal in numerous critical care applications and the removal of ticagrelor and rivaroxaban during cardiothoracic surgery. CytoSorb® has been used in more than 170,000 human treatments to date. Visit cytosorb.com to learn more.

 

SANTAIR S.A., a  leader in the field of medical devices and in vitro diagnostics, represents the largest Medical Device Companies worldwide.  Since its establishment in 1997, SANTAIR S.A. has adopted innovative and high-quality technologies and is established as a reliable provider with a continuous focus on development and high quality services in the healthcare industry, providing solutions with a wide range of capital equipment (medical devices, disposables, medical products for homecare), infrastructure (OR, ICU) and patient life support systems (ECMO).

 

Silver Sponsors

Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. We are driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape. For more information, visit Edwards.com and follow us on Facebook, Instagram, LinkedIn, Twitter and YouTube.

 

How to get there

The masterclass will start on November 25, 2022, and lasts through November 26, 2022.

It will be held in Buildings K8, K2, and K3 at the Hellenic Pasteur Institute, Athens, Greece (Vasilissis Sofias 127, Athina 115 21, Greece). Browse Google Map directions here

 

Weather information

The weather is expected to be partly sunny followed by clouds with minimum and maximum temperatures of 12 and 16 and 11 and 17 Celsius centigrade during the two days of the masterclass, respectively, check out more here

 

Health information 

Webpage for people travelling to Greece

Instructions for people using public transport

The most important requirement is: passengers are required to wear face masks/coverings (simple medical masks or cloth masks) while using Athens Transport or waiting at stations. 

 

The EACTAIC ECMO-LVAD masterclass is compliant with the MedTech Europe Code of Ethical Business Practice.

image001

Photos
Event Details
  • Start Date
    November 25, 2022 9:00 am
  • End Date
    November 26, 2022 7:00 pm
  • Status
    Expired
  • Address
    Vasilissis Sofias 127, Athens 115 21, Greece